Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | SLC5A1 | P13866 | 6/20 | 0.41 |
| ▸ | SLC5A2 | P31639 | 6/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20635533 | 0.93 | ITGB3 (0.45) | ACEPTPN1ITGB3ITGA2BCTSB | |
| SCHEMBL20634548 | 0.87 | SLC5A2 (0.45) | PTPN1SLC5A1SLC5A2ABCB1BCL2 | |
| SCHEMBL20635298 | 0.85 | PTPN1 (0.43) | ACEPTPN1ITGB3ITGA2BCTSB | |
| SCHEMBL26347434 | 0.84 | ITGB3 (0.53) | ACEPTPN1ITGB3ITGA2B | |
| SCHEMBL20634549 | 0.82 | PTPN1 (0.42) | ACEPTPN1ITGB3ITGA2BCTSS | |
| SCHEMBL24120438 | 0.81 | PTPN1 (0.40) | ACEPTPN1ITGB3ITGA2BSLC5A1 | |
| SCHEMBL22193920 | 0.81 | PTPN1 (0.40) | ACEPTPN1ITGB3ITGA2BSLC5A1 | |
| SCHEMBL24109496 | 0.79 | ITGB3 (0.37) | ACEPTPN1ITGB3ITGA2B | |
| SCHEMBL22193917 | 0.79 | PTPN1 (0.39) | ACEPTPN1ITGB3ITGA2BSLC5A1 | |
| SCHEMBL24109101 | 0.79 | ITGB3 (0.36) | ACEITGB3ITGA2BSLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-20210388017-A1 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | INTOCELL, INC. (KP) | 2021-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210388017-A1 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | VIP, ANTXR2, TNFRSF9 | ACE 1594/4885PTPN1 2150/4885ITGB3 2870/4885 |
| US-11753431-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | ACE 1594/4885PTPN1 2150/4885ITGB3 2870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.